Want to see JP:7061 full AI Analyst Report?
7061 Stock Chart & Stats
¥1120.00
¥7.00(0.51%)
At close: 4:00 PM EST
¥1120.00
¥7.00(0.51%)
Day’s Range― - ―
52-Week Range¥469.00 - ¥1,578.00
Previous CloseN/A
Volume53.20K
Average Volume (3M)47.89K
Market Cap
¥4.06B
Enterprise Value¥15.58K
Total Cash (Recent Filing)¥1.78B
Total Debt (Recent Filing)¥13.06B
Price to Earnings (P/E)12.4
Beta0.95
Next Earnings
Nov 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield5.17%
Share Statistics
EPS (TTM)35.87
Shares Outstanding8,484,100
10 Day Avg. Volume91,680
30 Day Avg. Volume47,890
Financial Highlights & Ratios
PEG Ratio-0.59
Price to Book (P/B)2.56
Price to Sales (P/S)0.66
P/FCF Ratio-7.11
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)199.5
Revenue Forecast (FY)¥20.00B
Bulls Say, Bears Say
Bulls Say
Revenue GrowthSustained revenue expansion indicates continued demand for the company’s hospice and care services. Growth provides a foundation for operating scale, although future benefit depends on restoring margins and controlling delivery costs.
Operating Cash FlowPositive operating cash generation shows that core operations are producing liquidity, which can support staffing, facility operations and investment. However, weak conversion from net income limits the strength of this benefit.
Essential-Care ModelHospice and palliative care are essential services supported by healthcare and long-term-care reimbursement systems. This creates an operating model linked to recurring patient-care activity rather than discretionary consumer spending.
Bears Say
Margin CompressionSharp gross, operating and net margin deterioration shows that rising costs are absorbing the benefit of revenue growth. Unless pricing, staffing efficiency or service mix improves, weaker profitability can constrain reinvestment and earnings recovery.
High LeverageThe large debt burden relative to equity reduces financial flexibility and increases dependence on stable operating performance. Elevated leverage may limit expansion choices and make the company more exposed to weaker earnings or funding pressure.
Negative Free Cash FlowPersistent negative free cash flow indicates that investment or working-capital needs are not being funded organically. Continued cash deficits can increase reliance on debt or external financing, particularly concerning given the company’s high leverage.
7061 FAQ
What was Japan Hospice Holdings Inc.’s price range in the past 12 months?
Japan Hospice Holdings Inc. lowest stock price was ¥469.00 and its highest was ¥1578.00 in the past 12 months.
What is Japan Hospice Holdings Inc.’s market cap?
Japan Hospice Holdings Inc.’s market cap is ¥4.06B.
When is Japan Hospice Holdings Inc.’s upcoming earnings report date?
Japan Hospice Holdings Inc.’s upcoming earnings report date is Nov 12, 2026 which is in 76 days.
How were Japan Hospice Holdings Inc.’s earnings last quarter?
Japan Hospice Holdings Inc. released its earnings results on Aug 14, 2026. The company reported ¥10.36 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Japan Hospice Holdings Inc. overvalued?
According to Wall Street analysts Japan Hospice Holdings Inc.’s price is currently Overvalued.
Does Japan Hospice Holdings Inc. pay dividends?
Japan Hospice Holdings Inc. pays a Annually dividend of ¥25 which represents an annual dividend yield of 5.17%. See more information on Japan Hospice Holdings Inc. dividends here
What is Japan Hospice Holdings Inc.’s EPS estimate?
Japan Hospice Holdings Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Japan Hospice Holdings Inc. have?
Japan Hospice Holdings Inc. has 8,484,100 shares outstanding.
What happened to Japan Hospice Holdings Inc.’s price movement after its last earnings report?
Japan Hospice Holdings Inc. reported an EPS of ¥10.36 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 0.358%.
Which hedge fund is a major shareholder of Japan Hospice Holdings Inc.?
Currently, no hedge funds are holding shares in JP:7061
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Japan Hospice Holdings Inc.
Japan Hospice Holdings Inc. operates in Japan, focusing on two primary areas: hospice residential care and a range of home-based support services. Its hospice facilities offer specialized care for patients facing terminal cancer and intractable diseases. Beyond residential care, the company provides home-visit nursing and broader home care services. These home care offerings include medical assistance, physical care, and support for daily living, alongside multi-functional day and nursing care programs. The company was founded in 2017 and is headquartered in Tokyo, Japan.
Technical Analysis
Care Twentyone Corporation
―
―
Care Service Co., Ltd.
―
Charm Care Corporation
―
Amvis Holdings.Inc.
―